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The recruitment of immune cells into solid tumors
is an essential prerequisite of tumor development.
Depending on the prevailing polarization profile of
these infiltrating leucocytes, tumorigenesis is either
promoted or blocked. Here, we identify IkB kinase
a (IKKa) as a central regulator of a tumoricidal micro-
environment during intestinal carcinogenesis. Mice
deficient in IKKa kinase activity are largely protected
from intestinal tumor development that is dependent
on the enhanced recruitment of interferon g (IFNg)-
expressing M1-like myeloid cells. In IKKa mutant
mice, M1-like polarization is not controlled in a cell-
autonomous manner but, rather, depends on the
interplay of both IKKamutant tumor epithelia and im-
mune cells. Because therapies aiming at the tumor
microenvironment rather than directly at the mutated
cancer cell may circumvent resistance development,
we suggest IKKa as a promising target for colorectal
cancer (CRC) therapy.INTRODUCTION
An inflammatory microenvironment is an essential component of
epithelial tumors that develop on the basis of chronic inflamma-
tory conditions as well as of those malignancies that emerge in
an inflammation-independent manner (Quante et al., 2013). In1914 Cell Reports 7, 1914–1925, June 26, 2014 ª2014 The Authorsboth instances, recruitment of various types of adaptive and
innate immune cells can be observed. Depending on the domi-
nating cell type and polarization profile of the infiltrating cells,
tumorigenesis is promoted or suppressed (Grivennikov et al.,
2010). Recently, an immune score relying on the intratumoral
localization of cytotoxic and memory T cells was established in
colorectal cancer (CRC) (Fridman et al., 2012). This immune
score has a powerful prognostic value and exemplifies the
importance of immune cells for this tumor entity. Moreover, a
large number of functional in vivo studies have provided sub-
stantial evidence demonstrating a key role of myeloid cells in
colorectal cancer as well as other tumor entities (Grivennikov
et al., 2010). In analogy to the Th1/Th2 classification of T cells,
macrophages have been suggested to be grouped into clas-
sically activated M1 (in response to interferon g [IFNg] or micro-
bial products) or alternatively activated M2 macrophages (in
response to interleukin 4 [IL-4]; Gordon and Taylor, 2005) In
the context of tumor-associated macrophages, M1 macro-
phages are considered to behave in a tumoricidal manner
whereas M2 macrophages promote tumorigenesis (Mantovani
et al., 2002). However, the exact molecular and cellular basis
underlying the tumor-promoting lymphocyte and myeloid cell
polarization within the tumor microenvironment is still poorly
defined.
Nuclear factor (NF)-kB activation leads to the establishment of
a protumorigenic inflammatory microenvironment of various ma-
lignancies (Bollrath andGreten, 2009). NF-kB is tightly controlled
by the IkB-kinase (IKK) complex, which consists of two catalytic
subunits, namely the IKKa and IKKb proteins, as well as the
regulatory subunit IKKg (Chariot, 2009). The classical NF-kB
activation controls key functions for tumor initiation, promotion,
and progression both in tumor as well as in infiltrating myeloid
cells (Karin and Greten, 2005). In contrast to classical IKKg/
IKKb-dependent NF-kB signaling, alternative NF-kB activation
depends solely on IKKa (Vallabhapurapu and Karin, 2009). More-
over, IKKa comprises a nuclear localization signal and can
therefore also confer important nuclear functions (Chariot,
2009). Whereas, in most malignancies, IKKb-dependent NF-kB
signaling clearly promotes tumorigenesis, the role of IKKa in
this context is more complex. Inhibition of IKKa prolongs survival
and suppresses occurrence of metastatic diseases in models of
mammary and prostate cancer (Cao et al., 2007; Luo et al., 2007;
Tan et al., 2011; Zhang et al., 2013). In contrast, loss of IKKa
enhances susceptibility to carcinogen-induced squamous cell
carcinomas (SCC) in the skin and leads to development of
spontaneous lung SCC (Liu et al., 2008; Xiao et al., 2013). Inter-
estingly, the latter depends in part on the development of an
excessive inflammatory environment triggered by IKKa mutant
macrophages (Xiao et al., 2013).
Globally sporadic CRC comprises the second most common
cause of cancer in women and the third most common cause
in men (Jemal et al., 2009). In over 80% of the cases, it is initiated
by APC and CTNNB mutations that cause persistent activation
of the Wnt pathway (Fearon, 2011). We could recently demon-
strate that proinflammatory IKKb-dependent NF-kB signaling
enhances b-catenin promoter binding, causing dedifferentiation
of postmitotic epithelia and tumor stem cell expansion during
Wnt-dependent tumor initiation (Schwitalla et al., 2013a).
Moreover, canonical NF-kB activation controls development
of epithelial-mesenchymal transition (EMT) and myeloid cell
recruitment in Tp53-deficient invasive carcinomas (Schwitalla
et al., 2013b). In contrast, IKKa directly phosphorylates b-cate-
nin, thus increasing its abundance to promote cyclin D1 expres-
sion (Albanese et al., 2003), and in colorectal cancer cells, an
active IKKa isoform was described (Margalef et al., 2012). How-
ever, functional genetic evidence supporting a cell autonomous
or nonautonomous role of IKKa and/or the alternative NF-kB
activation pathway in colorectal carcinogenesis is lacking.
RESULTS
Impaired IKKa Activation Suppresses Intestinal
Tumorigenesis
To functionally examine the role of IKKa during early intestinal
tumorigenesis, we employed IkkaAA/AA knockin mice, which
contain alanines instead of serines in the activation loop of IKKa
and express therefore a nonactivatable form of this kinase (Cao
et al., 2001). Whereas IkkaAA/AA mice are characterized by
impaired development of Peyer’s patches (Senftleben et al.,
2001), intestinal epithelial cell (IEC) differentiation was indistin-
guishable from littermate controls. IkkaAA/AAmice displayed regu-
lar numbers and distribution of goblet cells, Paneth cells, as well
as enteroendocrine cells (data not shown). Similarly, proliferation
and apoptosis rates of unchallenged intestinal epithelial cells in
small and large intestine were unaltered (data not shown). To
induce intestinal tumorigenesis, IkkaAA/AA mice and littermate
controls were repetitively challenged with the procarcinogen
azoxymethane (AOM), which is commonly used to induce ade-Cnoma growth in the distal colon of rodents. Expression of mutant
IKKa markedly reduced number of adenomas (>75%) when
animals were analyzed 20 weeks after the first carcinogen expo-
sure (Figure 1A). IkkaAA/AA mice developed only few relatively
small tumors that displayed slower proliferation rates (Figures
1B and 1C). Instead, in IkkaAA/AA mice multifocal low-grade intra-
epithelial neoplasia was frequently observed. To confirm the
IkkaAA/AA-dependent antitumorigenic effect in a genetic model
of adenomatous polyposis, we crossed IkkaAA/AA mice to
ApcMin/+ mice and monitored their survival. Similarly, loss of
IKKa functionconferredaprotective effect andprolongedsurvival
ofApcMin/+mice significantly (median survival of 236.5 days in ho-
mozygous IkkaAA/AA mutants versus 184.5 days in heterozygous
IkkaAA/WT mutants and 166 days in IkkaWT/WT wild-type ApcMin/+
mice; p < 0.0001; Figure 1D). Accordingly, when we analyzed
4-month-old ApcMin/+ animals, tumor incidence and size as well
as proliferation of tumor epithelia was significantly decreased
in IkkaAA/AA mutant mice (Figures 1E–1H; data not shown).
Furthermore, consistent with lower tumor burden, anemia—usu-
ally developing in ApcMin/+ mice as tumorigenesis progresses—
wasnormalized inApcMin/+/IkkaAA/AA compoundmutants (Figures
1I and 1J). Collectively, these results suggested that IkkaAA/AA
mediated antiproliferative effects during early tumor stages,
which led to marked tumor suppression in bothmodels of intesti-
nal tumorigenesis.
IkkaAA/AA Mice Block Tumor Cell Proliferation
Independently of Alternative NF-kB Activation
Tamoxifen-inducible b-catc.a. mice comprise an excellent model
to studyWnt-dependent tumor initiation. Thesemice are charac-
terized by IEC-restricted stabilization of b-catenin causing rapid
expansion of intestinal crypts and loss of differentiated IEC, and
within 4 weeks, b-catc.a. mice succumb to this marked crypt hy-
perproliferation (Schwitalla et al., 2013a). Similarly to the results
obtained in AOM-induced and Apc-dependent tumor models,
mutant IKKa blocked proliferation and expansion of c-myc-ex-
pressing b-catenin mutant crypts within 2 weeks after tamoxifen
induction (Figures 2A–2C). This was associated with decreased
CDK1 and CDK2 activity when mice were analyzed 15 days after
the first tamoxifen administration (Figures 2D and 2E). Accord-
ingly, impaired IKKa activation prolonged survival of b-catc.a.
mutant animals (Figure 2F). Interestingly, loss of NF-kB2/p100
did not affect survival, indicating that IKKa acted independently
of the alternative NF-kB activation pathway (Hayden and Ghosh,
2004). In line with this notion, we also did not observe any
differences in p100 processing in b-catc.a./IkkaAA/AA IEC (data
not shown).
Prolonged Survival of IKKaMutant b-catc.a. Mice
Depends on IFNg
To further explore the underlying IKKa-controlled proprolifera-
tive mechanism, we performed a microarray analysis comparing
RNA isolated from wild-type, IkkaAA/AA, b-catc.a., or b-catc.a./
IkkaAA/AA IEC 15 days after the first tamoxifen administration. A
total of 732 genes were significantly differentially expressed. In
IEC from b-catc.a./IkkaAA/AA compared to b-catc.a. mice, a gen-
eral downregulation of Wnt-dependent transcripts rather than
control of particular gene subsets was observed. These differentell Reports 7, 1914–1925, June 26, 2014 ª2014 The Authors 1915
Figure 1. Block of IKKa Activation Impairs Development of Carcinogen and Genetically Induced Intestinal Tumor Models
(A) Tumor incidence of IkkaWT/WT and IkkaAA/AA mice 20 weeks after the first of six weekly AOM treatments. Data are mean ± SE; n = 5 mice of each genotype;
**p < 0.01 by t test.
(B) Size distribution of AOM-induced tumors in IkkaWT/WT (n = 18) and IkkaAA/AA (n = 4)mice; n.d., not detectable; tumors of this size were not observed in IkkaAA/AA
mice.
(C) BrdU proliferation index of IkkaWT/WT and IkkaAA/AA tumor epithelia. Data are mean ± SE; nR 3 tumors of each genotype; *p < 0.05 by t test.
(D) Kaplan-Meier survival curve of ApcMin/+/IkkaWT/WT (n = 24), ApcMin/+/IkkaWT/AA (n = 16), and ApcMin/+/IkkaAA/AA (n = 24); ***p < 0.0001 by log rank test.
(E) Tumor incidence in small intestine and colon of ApcMin/+/IkkaWT/WT and ApcMin/+/IkkaAA/AA mice at 4 months. Data are mean ± SE; nR 6; *p < 0.05 by t test.
(F) Average tumor area in small intestine and colon of ApcMin/+/IkkaWT/WT and ApcMin/+/IkkaAA/AA mice at 4 months. Data are mean ± SE; nR 15 tumors of each
genotype; *p < 0.05 by t test.
(G and H) Representative hematoxylin and eosin (H&E)-stained sections of colons from ApcMin/+/IkkaWT/WT (G) and ApcMin/+/IkkaAA/AA (H) mice at 4 months; scale
bar = 1 mm. Arrowhead indicates adenoma.
(I and J) Hemoglobin (I) and hematocrit (J) levels of ApcMin/+/IkkaWT/WT and ApcMin/+/IkkaAA/AA mice at 4 months. Data are mean ± SE; nR 5 of each genotype;
**p < 0.01 and *p < 0.05 by t test.transcription profiles supposedly reflected the observed differ-
ences in IECmorphology between the twogenotypes (Figure 2A),
but not distinct IKKa-controlled signaling events. Indeed, knock-
down of IKKa did not decrease b-catenin binding to its Tcf/Lef
motif in human embryonic kidney 293 cells when transfected
with a constitutively active b-catenin mutant (Figure S1). There-1916 Cell Reports 7, 1914–1925, June 26, 2014 ª2014 The Authorsfore, we focused our attention on the group of transcripts that
were markedly upregulated in IEC from b-catc.a./IkkaAA/AA
mice. These could be classified into genes associated with im-
mune response and inflammatory functions when sorted by their
membership in KEGG pathways (Figure 3A). More specifically,
gene set enrichment analysis (GSEA) indicated an enrichment
Figure 2. Reduced Proliferation in IKKa-Activation-Impaired Mice Is due to G1 Cell Cycle Arrest and Is Independent of Alternative NF-kB
Activation
(A) H&E staining as well as immunohistochemical analysis of BrdU and c-Myc in small intestine of wild-type, IkkaAA/AA, b-catc.a., and b-catc.a./IkkaAA/AA mice
15 days after the first tamoxifen application. The scale bar represents 100 mm.
(B) BrdU proliferation index of epithelial cells in unchallenged wild-type and IkkaAA/AA mice as well as b-catc.a. and b-catc.a./IkkaAA/AA mice 15 days after first
tamoxifen administration. Data are mean ± SE; n = 3 for all genotypes; **p < 0.01 by t test.
(C) Immunoblot analysis of b-catenin, IKKa, IKKb, and c-Myc in b-catc.a./IkkaWT/WT and b-catc.a./IkkaAA/AA mice IEC lysates at 0 or 15 days after first tamoxifen
injection.
(D and E) Kinase assays (D), loading controls, and (E) loading-corrected relative kinase activities for endogenous CDK1, CDK2, and CDK4 in IEC from un-
challenged wild-type and IkkaAA/AA mice as well as b-catc.a. and b-catc.a./IkkaAA/AA mice 15 days after first tamoxifen application. Data are mean ± SE; n = 2 for all
genotypes; *p < 0.05 and **p < 0.01 by ANOVA followed by Bonferroni post hoc test for multiple data sets. GST, glutathione S-transferase; IP, immunopre-
cipitation; WB, western blot.
(F) Kaplan-Meier survival graph for b-catc.a./IkkaWT/WT (n = 11), b-catc.a./IkkaWT/AA (n = 7), b-catc.a./IkkaAA/AA (n = 10), and b-catc.a./Nfkb2/ (n = 8) mice; **p < 0.01
by log rank test.
See also Figure S1.of type I and II IFN targets in b-catc.a./IkkaAA/AA IEC (Figure 3B),
including Stat1, Irf1, Nos2, Oas1, Pkr, and Isg15, which could
be confirmed by real-time PCR (Figure 3C). This was paralleled
by a marked upregulation of IFNg in whole mucosa of b-catc.a./
IkkaAA/AA mice (Figure 3D). Moreover, immunoblot analysis
confirmed activation of tyrosine-phosphorylated Stat1(Y701) as
well as upregulation of Nos2 and IRF-1 in IKKa mutant IEC
(Figure 3E). Because IFNg/Stat1 signaling is known to suppress
tumor cell proliferation, this raised the possibility that the
decreased IEC proliferation in b-catc.a./IkkaAA/AA mice was
non-cell-autonomous and IFNg dependent. To confirm this
hypothesis, we either adoptively transferred IkkaAA/AA bone
marrow to b-catc.a. mice or used conditional IkkaF/F mutants to
specifically delete IKKa in b-catc.a. IEC (Liu et al., 2008). IEC-
restricted deletion of IKKa only moderately protected b-catc.a.
mice (Figure 4A). In contrast, adoptive transfer of IkkaAA/AA
bone marrow extended survival of b-catc.a. mice almost to the
same extent as it was otherwise seen in IkkaAA/AA whole-bodyCmutants (Figure 4B). More importantly, loss of Ifng, but not
blocking type I interferon signaling by Ifnar deletion, completely
prevented IKKa-mediated survival advantage (Figure 4C).
Collectively, these data provided clear evidence that mutant
IKKa suppressed IEC proliferation in a paracrine type II inter-
feron-dependent manner.
IkkaAA/AA Myeloid Cells Rather Than T or NK Cells
Comprise the Source of IFNg
The most common IFNg-expressing cell types in the lamina
propria are T and natural killer (NK) cells. Surprisingly, we did
not detect any difference in the number of mucosa-infiltrating
CD3+ T cells by immunohistochemistry (Figure 5A). Moreover,
fluorescence-activated cell sorting (FACS) analysis did not indi-
cate changes in the number of CD4+IFNg+ or CD8+IFNg+ T cells
between b-catc.a. and b-catc.a./IkkaAA/AA mice when animals
were analyzed 15 days after the first tamoxifen administration
(Figure 5B). Moreover, when we differentiated naive T cellsell Reports 7, 1914–1925, June 26, 2014 ª2014 The Authors 1917
Figure 3. Generation of an IFNg-Dominated Microenvironment in the Mucosa of b-catc.a./IkkaAA/AA Mice
(A) KEGG pathway analysis of the genes significantly upregulated in b-catc.a./IkkaAA/AA mice IECs 15 days after first tamoxifen administration.
(B) Gene set enrichment analysis (GSEA) comparing expression of all genes with a combined data set of interferon-regulated genes (Browne et al., 2001; Zhang
et al., 2005; Bosco et al., 2010; Einav et al., 2005; Natsume et al., 2005; Reactome database; STKE database) in b-catc.a./IkkaWT/WT versus b-catc.a./IkkaAA/AAmice
IECs 15 days after first tamoxifen injection; normalized enrichment score = 2.03; ***p < 0.001.
(C and D) Real-time PCR expression analysis of indicated genes in mucosa from wild-type, IkkaAA/AA, b-catc.a., and b-catc.a./IkkaAA/AA mice 15 days after the first
tamoxifen application. Data are mean ± SE; nR 3 for all genotypes. *p < 0.05; ***p < 0.001 by ANOVA followed by Bonferroni post hoc test for multiple data sets.
(E) Immunoblot analysis of IFNg downstream targets p-STAT1, STAT1, IRF1, and iNOS in small-intestinal IEC from wild-type, IkkaAA/AA, b-catc.a., and b-catc.a./
IkkaAA/AA mice 15 days after the first tamoxifen application.from either wild-type or IkkaAA/AA animals into either Th1 or Th2
cells ex vivo, we were not able to determine any significant
changes between the two genotypes (Figure S2A). Conse-
quently, athymic nude mice (NU-Foxn1nu) that lack T cells did
not revert the survival advantage of b-catc.a./IkkaAA/AA mice
(data not shown). In addition, also depletion of NK cells using
a-asialo-GM-1 antibody (reduction of >90% of splenic DX5+
cells was confirmed by FACS; data not shown) did not affect
survival of b-catc.a./IkkaAA/AA mice (Figure 5C), indicating that
neither CD4+, CD8+ T cells, nor NK cells were responsible
for the IFNg-mediated survival extension of IkkaAA/AA mutant
b-catc.a. mice.1918 Cell Reports 7, 1914–1925, June 26, 2014 ª2014 The AuthorsDuring carcinogenesis, polarization of myeloid cells into M1 or
M2 macrophages or in the case of neutrophils into N1 or N2 has
been suggested to play an important role for tumor development
(Sica and Mantovani, 2012). Depending on the prevailing polari-
zation profile, M1 macrophages (typically expressing Ifng, Tnfa,
Il12, Nos2, Cxcl9, Cxcl10, and Cxcl11) are considered tumorici-
dal, whereas M2 macrophages (characterized by high levels of
Arg1,Mrc1, Ccl17,Ccl22, Ym1, and Fizz1) have been suggested
to promote tumorigenesis (Sica and Mantovani, 2012). Consid-
ering the lack of T and NK cell involvement in the pronounced
expression of Nos2 and Ifng, we speculated that instead a gen-
eral shift in macrophage polarization towardM1 could have been
Figure 4. Improved Survival of b-catc.a./
IkkaAA/AA Mice Depends on IFNg
(A) Kaplan-Meier survival graph of b-catc.a./
IkkaDIEC mice (violet line). Survival of b-catc.a./
IkkaWT/WT and b-catc.a./IkkaAA/AA mice shown as
comparison (dashed gray lines; p = not signif-
icant [n.s.]).
(B) Kaplan-Meier survival graph of lethally irradi-
ated b-catc.a./IkkaWT/WT mice transplanted with
either IkkaWT/WT (n = 6; red line) or IkkaAA/AA (n = 7;
blue line) bone marrow; ***p < 0.001 by log rank
test.
(C) Kaplan-Meier survival graph of b-catc.a./
IkkaWT/WT/Ifng/ (n = 9; light blue line), b-catc.a./
IkkaAA/AA /Ifng/ (n = 5; red line; **p < 0.005), and
b-catc.a./IkkaAA/AA/ Ifnar1/ mice (n = 8; pink
line; p > 0.05) mice. Survival of b-catc.a./IkkaWT/WT
and b-catc.a./IkkaAA/AA mice shown as comparison
(dashed gray lines).responsible for this. Indeed, besides Nos2 and Ifng, expression
of several other genes encoding M1 markers were elevated in
the lamina propria of b-catc.a./IkkaAA/AA mice 15 days after the
first tamoxifen administration, whereas only Ccl17 among M2-
associated genes was downregulated (Figure 6A). To examine
whether IkkaAA/AA mutant macrophages per se would reveal an
M1 phenotype, we stimulated bone-marrow-derived macro-
phages (BMDM) under M1- or M2-polarizing conditions. Inter-
estingly, ex vivo IkkaAA/AA macrophages did not reveal an
enhanced M1 polarization profile compared to control BMDM
and did not show a preferred polarization (Figure 6B). Moreover,
also Ifng expression was indifferent when BMDM of either geno-
type were stimulated with a combination of IL-12 and IL-18
(Figure S2C), thus ruling out a cell autonomous regulation in
the generation of IkkaAA/AA M1-like cells in vivo.
Elevated expression levels of myeloid-recruiting chemokines
such as Cxcl1, Cxcl2, Cxcl5, and Ccl2 (Figure 6C) led to
enhanced recruitment of macrophages, neutrophils, and den-
dritic cells into the lamina propria of b-catc.a./IkkaAA/AA mutants,
as determined by real-time PCR of genes encoding surface
markers Emr1, Ly6g, and Itgax (Figure 6D) as well as by FACS
analysis (data not shown). Only Cxcl1 and Cxcl2 upregulationCell Reports 7, 1914–192was observed in IKKa mutant epithelia
(Figure 6C), indicating that Cxcl5
and Ccl2 were derived from infiltrating
immune cells. Interestingly, apart from
enhanced myeloid cell recruitment, also
localization of both macrophages and
neutrophils was distinct in b-catc.a./
IkkaAA/AA mice, where they could be
found interspersed in between IEC. In
contrast, infiltration of F4/80+ and Gr-1+
myeloid cells was limited to the villus
stroma in IKKa wild-type-expressing
b-catc.a. mice (Figures 6E–6H). Impor-
tantly, immunofluorescence confirmed
that indeed both macrophages and neu-
trophils expressed IFNg (Figures 6I and6J), indicating that an enhanced recruitment of M1-like myeloid
cells was responsible for the IFNg-dependent survival advan-
tage of b-catc.a./IkkaAA/AA mice.
Enhanced Recruitment of Myeloid Cells Depends on
IKKb Activation in b-catc.a./IkkaAA/AA IEC
Myeloid-cell-recruiting chemokines such as Cxcl1, Cxcl2, Cxcl5,
and Ccl2 are controlled by classical NF-kB activation (Grivenni-
kov et al., 2010). To functionally confirm that indeed the
enhanced recruitment of M1-like myeloid cells was responsible
for the extended survival in b-catc.a./IkkaAA/AAmice, we reasoned
that loss of IKKb-dependent NF-kB activation in IEC should
block recruitment of myeloid cells in IKKa mutant b-catc.a. ani-
mals. Thus, we intercrossed floxed Ikkb mutants (IkkbF/F) with
b-catc.a./IkkaAA/AA mice to generate b-catc.a./IkkaAA/AA/IkkbDIEC
as well as b-catc.a./IkkbDIEC compound mutants. Expectedly,
IKKb deletion decreased Cxcl1 and Ccl2 as well as Emr1,
Ly6g, and Itgax expression and prevented Ifng upregulation (Fig-
ure 7A). Immunofluorescence confirmed diminished F4/80+ and
Gr-1+ cell infiltration into mucosa of b-catc.a./IkkaAA/AA/IkkbDIEC
animals (Figures 7B–7E). We recently demonstrated that loss
of RelA/p65 expanded the life span of b-catc.a. mice (Schwitalla5, June 26, 2014 ª2014 The Authors 1919
Figure 5. IKKa Mutant T Cells and NK Cells Do Not Contribute to
Elevated IFNg Expression in b-catc.a. Mice
(A) Immunohistochemical analysis of CD3 in small intestine of b-catc.a. and
b-catc.a./IkkaAA/AA mice 15 days after the first tamoxifen application. The scale
bar represents 100 mm.
(B) FACS analysis of CD4+IFNg+ or CD8+IFNg+ mucosa infiltrating lymphoid
cells isolated from b-catc.a./IkkaWT/WT and b-catc.a./IkkaAA/AA mice small in-
testinal mucosa 15 days after first tamoxifen administration. T cells were re-
stimulated using PMA (20 ng/ml) and ionomycin (1 mg/ml) for 6 hr in the
presence of Brefeldin A. Data are mean ± SE; n = 2.
(C) Kaplan-Meier survival graph of b-catc.a./IkkaAA/AA mice injected with
a-asialo-GM1 antibody (n = 6; green line). Survival of b-catc.a./IkkaWT/WT and
b-catc.a./IkkaAA/AA mice shown as comparison (dashed gray lines; p = n.s.).et al., 2013a). Similarly, deletion of Ikkb prolonged survival of
Ctnnb mutants (Figure 7F). However, consistent with a lack of
Ifng induction, b-catc.a./IkkaAA/AA animals were no longer pro-
tected in the absence of IKKb and their survival was now compa-
rable to that of b-catc.a./IkkbDIEC mice (Figure 7F). Thus, these
data further supported the importance of IFNg-expressing
myeloid cells for the survival of b-catc.a./IkkaAA/AA mice and
confirmed that M1-like polarization did not occur in a cell auton-
omous manner in IKKa mutant myeloid cells.
DISCUSSION
Cell plasticity is an important phenomenon during carcinogen-
esis that affects basically all cells in the tumor microenvironment
(Hanahan and Weinberg, 2011). Whereas induction of EMT
altering tumor cells themselves is an essential prerequisite for
invasion and metastasis, polarization of infiltrating immune cells
provides the microenvironment-dominating cytokine milieu,
which ultimately controls behavior of resident stromal and tumor
cells. Depending on the cytokine milieu, carcinogenesis is pro-
moted or suppressed (Grivennikov et al., 2010). To decipher the1920 Cell Reports 7, 1914–1925, June 26, 2014 ª2014 The Authorscellular and molecular mechanisms that shape the cytokine
milieu bears great therapeutic potential, because cytokine-pro-
ducing immune cells are unlikely to develop resistance mecha-
nisms in contrast to mutagenized tumor cells. Although IKKa
has been suggested to control various cell autonomous tu-
mor-promoting mechanisms in CRC (Albanese et al., 2003;
Margalef et al., 2012), here we provide evidence that IKKa com-
prises a central regulatory element in the suppression of M1-like
myeloid cell controlled microenvironment rather than directly
stimulating tumor cell proliferation. Elevated IFNg levels in
IkkaAA/AA mucosa are most likely responsible for growth arrest
of initiated epithelial cells. However, considering the particular
intraepithelial localization of myeloid cells in b-catc.a./IkkaAA/AA
mice, we cannot rule out the possibility that these cells may
also participate either in extracellular killing or phagocytosis of
tumor cells as it was recently demonstrated using oncogenic
HRAS(G12V)-transformed cells in zebrafish larvae (Feng et al.,
2010).
Importantly, polarization of IKKa mutant myeloid cells de-
pends on a complex interplay of IEC and infiltrating cells and
is not a cell autonomously controlled process. Instead, it in-
volves classical NF-kB-dependent secretion of chemokines in
IkkaAA/AA IEC that triggers recruitment of myeloid cells, which
in turn secrete cytokines that culminate in M1 polarization
and fuel into a feedforward loop that drives IFNg secretion.
This is further supported by the fact that administration of IL-
12-neutralizing antibodies is not sufficient to block this loop
and to prevent IFNg secretion (S.I.G. and F.R.G., unpublished
data). However, prevention of myeloid cell infiltration and sub-
sequent ablation of M1-like polarization can be achieved by in-
hibition of NF-kB activation in IEC. Considering that IKKa
expression correlates with poor prognosis in human Union for
International Cancer Control stage II CRC (S.I.G. and F.R.G.,
unpublished data), whereas IFNg upregulation is associated
with improved survival (Grenz et al., 2013), IKKa may represent
a valuable therapeutic target for CRC therapy or prevention. If,
however, putative IKKa inhibitors were indeed at some point
considered for CRC therapy, our data imply that such com-
pounds are required to be highly specific inhibitors of only
IKKa because simultaneous overlapping IKKb inhibition would
most likely prevent the beneficial effects of selective IKKa
inhibition.
We recently demonstrated that, during Wnt-initiated tumori-
genesis, NF-kB activation cooperates with b-catenin to control
dedifferentiation of postmitotic epithelia and stem cell expansion
(Schwitalla et al., 2013a). Although in IKKa mutant IEC chemo-
kine expression is enhanced in an NF-kB-dependent manner,
we do not have any evidence that Wnt signaling is enhanced in
IkkaAA/AA IEC as well. This supports the notion that IKKa is
responsible for the negative regulation of a very distinct set of
NF-kB target genes only (Lawrence et al., 2005; Schwitalla
et al., 2013a).
Depending on the type of malignancy, IKKa can provide both
tumor-promoting and tumor-suppressive mechanisms that are
in most instances cell autonomous. IKKa controls expression
of the inhibitor of metastasis maspin in breast and prostate
cancer (Luo et al., 2007; Tan et al., 2011) and is required
for ErbB2-induced mammary tumorigenesis. In the latter case,
Figure 6. M1-like Polarized Myeloid Cells
Are Source of IFNg in b-catc.a./IkkaAA/AA
Mice
(A) Real-time PCR expression analysis of M1 (red)
and M2 (blue) macrophage markers in lamina
propria samples from b-catc.a./IkkaWT/WT and
b-catc.a./IkkaAA/AA mice 15 days after first tamox-
ifen administration. Data shown represent fold
difference of Ct values from b-catc.a./IkkaAA/AA
versus b-catc.a./IkkaWT/WT mice. Data are mean ±
SE; nR 3 for both genotypes.
(B) Real-time PCR expression analysis of M1 (red)
and M2 (blue) macrophage markers in bone-
marrow-derived macrophages (BMDM) from
IkkaWT/WT and IkkaAA/AA mice that have been
stimulated with a mix of IFNg (5 ng/ml) and lipo-
polysaccharide (100 ng/ml; M1 markers) or IL-4
(10 ng/ml; M2 markers) for 4 hr. Data shown
represent fold difference of Ct values from
IkkaAA/AA versus IkkaWT/WT mice. Data are mean ±
SE; n = 3 for both genotypes.
(C) Real-time PCR expression analysis of chemo-
kines Cxcl1, Cxl2, Cxcl5, and Ccl2 in whole mu-
cosa samples or IEC from unchallenged wild-type
and IkkaAA/AA mice as well as b-catc.a. and
b-catc.a./IkkaAA/AA mice 15 days after first tamox-
ifen application. Data are mean ± SE; nR 3 for all
genotypes. *p < 0.05, ***p < 0.001 by ANOVA
followed by Bonferroni post hoc test for multiple
data sets.
(D) RT-PCR expression analysis of myeloid
cell markers Emr1, Ly6g, and Itgax in whole mu-
cosa samples from unchallenged wild-type and
IkkaAA/AA mice as well as b-catc.a. and b-catc.a./
IkkaAA/AA mice 15 days after first tamoxifen appli-
cation. Data are mean ± SE; n R 3 for all geno-
types. *p < 0.05; ***p < 0.001 by t test.
(E–H) Immunofluorescence staining of myeloid cell
markers F4/80 (E and G) and Gr-1 (F and H) in
small intestine of b-catc.a./IkkaWT/WT and b-catc.a./
IkkaAA/AA mice 15 days after first tamoxifen appli-
cation. The scale bar represents 25 mm.
(I and J) Coimmunofluorescence of F4/80 and
IFNg (I) as well as Gr-1 and IFNg (J) in small in-
testine of b-catc.a./IkkaAA/AA mice 15 days after
first tamoxifen application.
See also Figure S2.NIK-dependent IKKa activation regulates expansion of tumor-
initiating cells by directly phosphorylating the cyclin-dependent
kinase inhibitorp27 (Zhangetal., 2013). Additional tumor-promot-
ing nuclear functions of IKKa include cell cycle regulation and
chromosomal accessibility by phosphorylation of histone H3,
AuroraB kinase, or the nuclear corepressor SMRT, which triggers
its nuclear exportwithHDAC3and itsdegradation (Chariot, 2009).
In contrast, IKKa acts as a tumor suppressor in models of skin orCell Reports 7, 1914–192lung SCC (Liu et al., 2008; Xiao et al.,
2013). Importantly, during development
of lung SCC, IKKa kinase inactivation cul-
minates in the recruitment of tumor-pro-
moting inflammatory macrophages and
depletion of macrophages prevents SCCformation (Xiao et al., 2013). This is in clear contrast to our findings
presented here, yet the reason for this diverse macrophage acti-
vation profile in these two different tumor entities remains
currently unclear. One could envision that specific alterations in
the intestinal microbiome of IkkaAA/AA mice may be involved in
the tumor-suppressive M1 polarization of myeloid cells that only
becomes apparent after barrier defect causing oncogene activa-
tion (Grivennikov et al., 2012).5, June 26, 2014 ª2014 The Authors 1921
Figure 7. Enhanced Recruitment and Acti-
vation of Myeloid Cells in b-catc.a./IkkaAA/AA
Mice Depend on IKKb-Dependent NF-kB
Activation in IEC
(A) Real-time PCR analysis of indicated genes
in b-catc.a./IkkaWT/WT, b-catc.a./IkkaAA/AA, and
b-catc.a./IkkaAA/AA/IkkbDIEC mice whole mucosa
samples 15 days after first tamoxifen application.
Data are mean ± SE; nR 3 for all genotypes. *p <
0.05; ***p < 0.001 by ANOVA followed by Bonfer-
roni post hoc test for multiple data sets.
(B–E) Immunofluorescent staining of F4/80 (B and
C) and Gr-1 (D and E) in small intestine of b-catc.a./
IkkaAA/AA and b-catc.a./IkkaAA/AA/IkkbDIEC mice
15 days after first tamoxifen administration. The
scale bar represents 50 mm.
(F) Kaplan-Meier survival graph of b-catc.a./
IkkbDIEC (n = 11; red line) and b-catc.a./IkkaAA/AA/
IkkbDIEC mice (n = 6; blue line). Survival of b-catc.a./
IkkaWT/WT and b-catc.a./IkkaAA/AA mice shown as
comparison (dashed gray lines).
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EXPERIMENTAL PROCEDURES
Mice
IkkaAA/AA (Cao et al., 2001), IkkaF/F (Liu et al., 2008), IkkbF/F (Greten et al., 2004),
Nfkb2/ (Paxian et al., 2002), and b-catc.a. (Schwitalla et al., 2013a) mice have
been recently described. C57BL/6ApcMin/+, Ifng/, and NU-Foxn1nu mice
were purchased from the Jackson Laboratories, and Ifnar/ mice were pro-
vided by F. Schmitz, TU Munich. To examine AOM-induced tumorigenesis,
mice had been backcrossed to a FVB background for four generations, and
littermate controls were used in all experiments. Before crossing to C57BL/
6ApcMin/+ mice, IkkaAA/AA animals had been backcrossed to a C57BL/6
background for eight generations. Experiments using b-catc.a. mutants were
performed on a mixed C57BL/63 129Sv3 FVB background, and in all exper-
iments, littermate controls were used. Tamoxifen (Sigma; 1 mg in an ethanol/
sunflower oil mixture) was applied by oral gavage on 5 consecutive days.
Azoxymethane (10 mg/kg; Sigma) was injected intraperitoneally (i.p.) once
weekly for 6 weeks. In adoptive transfer experiments, recipient mice were irra-
diated (9 Gy) and 23 106 bone marrow cells from IkkaAA/AA mice or IkkaWT/WT
littermate controls were transferred by tail vein injection. Eight weeks after
transplantation, tamoxifen administration was started. To deplete NK cells,
200 mg a-Asialo GM1 antibody (no. 986-10001; Wako) was injected i.p. every
4 days. All procedures were reviewed and approved by the Regierung von
Oberbayern.
Protein Analysis
Isolation of enterocytes, immunoblot analysis, immune complex kinase assay,
and DNA affinity precipitation assay were performed as described previously
(Bollrath et al., 2009; Schwitalla et al., 2013a). The following antibodies were
used: anti-IKKa (IMG136A; Imgenex), anti-IKKb (05-535; Upstate), anti-b-actin
(A4700; Sigma), anti-b-catenin (UBI 6734; United Bio Research), anti-phos-
pho-STAT1 (9171; Cell Signaling Technology), anti-STAT1 (SC-346; Santa
Cruz Biotechnology), anti-c-Myc (SC-788), anti-IRF-1 (SC-640), anti-NOS2
(SC-651), anti-Cdc2 (SC-54), anti-Cdk2 (SC-163), anti-Cdk4 (SC-260), and
anti-b-catenin (SC-1496).
Histological Procedures and Flow Cytometry
Standard immunohistochemical procedures were performed using the
following antibodies: anti-bromodeoxyuridine (BrdU) antibody (RPN201; GE
Healthcare), anti-IKKa (Abcam; ab109749; clone EPR464), CD68 (Fisher
Scientific; MS-397; clone KP1), anti-c-myc (SC-788), anti-F4/80 (Caltag; MF
480043), anti-Gr-1 (eBioscience; 12-5931-85), and anti-IFNg (R&D Systems;
BAF 485). For the isolation of lamina propria cells, intestines of mice were
opened longitudinally, cleared of mucus, chopped into small pieces, and
shook in Hank’s balanced salt solution (Invitrogen) containing 30 mM EDTA
(Sigma-Aldrich) at 37C for 20 min followed by 30 s of heavy vortexing to
detach the epithelial layer. The remaining tissue pieces were washed at least
five times in PBS and then digested in RPMI (Invitrogen) containing 1 mg/ml
collagenase I (Sigma-Aldrich) and 20 mg/ml DNase I (Sigma-Aldrich) for
90 min at 37C while gently shaking. Liberated cells were then washed in
RPMI containing 10% fetal calf serum (Biochrom) and 1% penicillin-strepto-
mycin (Invitrogen). T cells were restimulated using phorbol myristate acetate
(PMA) (20 ng/ml) and ionomycin (1 mg/ml) for 6 hr in the presence of Brefeldin
A (10 mg/ml; Sigma-Aldrich). Flow cytometric analysis was performed on a
Gallios flow cytometer (Beckman Coulter Genomics) or a FACSCalibur (Bec-
ton Dickinson), and results were analyzed using FlowJo software (Tree Star).
The following fluorochrome-conjugated antibodies were used: fluorescein
isothiocyanate-anti-CD4 (BD-557653), phycoerythrin (PE)-anti-CD4 (BD-
553651), PE-anti-CD8 (BD-550798), and PE-anti-IFNg (BD-554412).
RNA Analysis
Total RNA extraction, cDNA synthesis, real-time PCR and gene expression
profiling, and GSEA were performed as described previously (Bennecke
et al., 2010). Primer sequences are available on request. In GSEA, wematched
various interferon-related gene sets from GSEA Software Database (Bosco
et al., 2010; Browne et al., 2001; Einav et al., 2005; Natsume et al., 2005;
Zhang et al., 2005), Reactome database (http://www.reactome.org/cgi-bin/
eventbrowser_st_id?ST_ID=REACT_25229), and STKE database to all tran-Cscripts from the Affymetrix Mouse Genome 430A 2.0 Array, respectively.
GSEA software is available from Broad Institute of MIT and Harvard University
(http://www.broadinstitute.org/gsea/index.jsp). We acknowledge the use of
GSEA software (Subramanian et al., 2005) to validate correlation between mo-
lecular pathways signatures in any phenotype of interest. For the analysis of
gene sets, we modified default parameters as follows: permutation number
to 1,000, collapse data set to gene symbols if ‘‘false,’’ permutation type to gen-
e_sets, and only gene sets with the size of 1–2,000 signatures were used for
analysis.
In Vitro Antigen Presentation Assay
Bone-marrow-derived dendritic cells (BMDC) were differentiated from wild-
type (WT) and IkkaAA/AA bone marrow in RPMI supplemented with 20 ng/ml
GM-CSF for 7 days. On day 7, BMDCs were loaded with ovalbumin
(0.5 mg/ml) at 37C for 1 hr. T cells from spleens of OT II mice (Jackson Lab-
oratories) were purified using a CD4+CD62L+ T cell isolation Kit (Miltenyi
Biotech) and carboxyfluorescein succinimidyl ester (CFSE)-labeled (5 mM;
10 min; 37C). In 96-well plates, 1 3 104 BMDCs were coincubated with 1 3
105 CFSE-labeled OT II cells for 72 hr. Subsequently, cultures were stimulated
with PMA (20 ng/ml) for 6 hr, T cell proliferation was analyzed by FACS analysis
on a FACS Calibur, and IFNg production was determined by ELISA.
Directed Differentiation of Naive CD4+ T Cells
Purified naive TH cells (CD4
+CD62L+) were stimulated with anti-CD28 anti-
body (2 mg/ml; eBioscience) and anti-CD3e-antibody (145-2C11; 5 mg/ml;
eBioscience), which had been bound to cell culture plates by anti-Syrian ham-
ster antibody (10 mg/ml; Jackson ImmunoResearch). Cells were directed into
the TH1 line by treatment with IL-12 (2 ng/ml; R&D Systems). Anti-IL-4 antibody
was added (10 mg/ml; BD Biosciences) to prevent differentiation toward
the TH2 line. Differentiation toward the TH2 line was achieved using IL-4
(10 ng/ml; R&D Systems) in the presence of anti-IFN-g antibody (10 mg/ml;
eBioscience) to suppress differentiation into TH1 cells. Cells were collected
for real-time PCR analysis, and RNA was isolated using TRI reagent (Sigma-
Aldrich). To confirm successful differentiation, cells were tested for their
capacity to produce IFN-g (TH1) or IL-4 (TH2). For that purpose, cells were har-
vested after the 3-day stimulation, washed, and incubated without stimulus
but in presence of IL-2 (10 ng/ml; R&D Systems) for 3 additional days. After-
ward, the cells were collected, restimulated with plate-bound anti-CD3 anti-
body (see above) in the presence of Brefeldin A (10 mg/ml, Sigma-Aldrich),
and intracellular cytokine staining was performed.
Statistical Analysis
Data are expressed as mean ± SE. Statistical analysis methods were standard
two-tailed Student’s t test for two data sets and ANOVA followed by Bonferroni
post hoc test for multiple data sets or log rank test for Kaplan-Meier survival
graphs using Prism4 (GraphPad Software) or SPSS Statistics 21. p values%
0.05 were considered significant.
ACCESSION NUMBERS
Gene expression data have been deposited in the Gene Expression Omnibus
database under accession number GSE51631.
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